Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP565907.RAA2Sx2Iq58oumR2dMfWEXo9MfFBrrOv_95Ay1Ph5EBhg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP565907.RAA2Sx2Iq58oumR2dMfWEXo9MfFBrrOv_95Ay1Ph5EBhg130_assertion type Assertion NP565907.RAA2Sx2Iq58oumR2dMfWEXo9MfFBrrOv_95Ay1Ph5EBhg130_head.
- NP565907.RAA2Sx2Iq58oumR2dMfWEXo9MfFBrrOv_95Ay1Ph5EBhg130_assertion description "[The fusion gene BCR-ABL in chronic myeloid leukemia (CML), FLT3/ITD in acute myeloid leukemia (AML), and RAS mutations in myelodysplastic syndromes (MDS)/myeloproliferative diseases (MPD) result in ROS production.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP565907.RAA2Sx2Iq58oumR2dMfWEXo9MfFBrrOv_95Ay1Ph5EBhg130_provenance.
- NP565907.RAA2Sx2Iq58oumR2dMfWEXo9MfFBrrOv_95Ay1Ph5EBhg130_assertion evidence source_evidence_literature NP565907.RAA2Sx2Iq58oumR2dMfWEXo9MfFBrrOv_95Ay1Ph5EBhg130_provenance.
- NP565907.RAA2Sx2Iq58oumR2dMfWEXo9MfFBrrOv_95Ay1Ph5EBhg130_assertion SIO_000772 18467025 NP565907.RAA2Sx2Iq58oumR2dMfWEXo9MfFBrrOv_95Ay1Ph5EBhg130_provenance.
- NP565907.RAA2Sx2Iq58oumR2dMfWEXo9MfFBrrOv_95Ay1Ph5EBhg130_assertion wasDerivedFrom befree-20140225 NP565907.RAA2Sx2Iq58oumR2dMfWEXo9MfFBrrOv_95Ay1Ph5EBhg130_provenance.
- NP565907.RAA2Sx2Iq58oumR2dMfWEXo9MfFBrrOv_95Ay1Ph5EBhg130_assertion wasGeneratedBy ECO_0000203 NP565907.RAA2Sx2Iq58oumR2dMfWEXo9MfFBrrOv_95Ay1Ph5EBhg130_provenance.